og体育
join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
og体育:Quality Management
Contact Us
Legal Statement
og体育:Adverse Reaction Report
Science and Technology
og体育:R&D platform
R&D pipeline
og体育:Therapeutic Field
International Business
APIs
Finished Products
og体育:Medical device
Download product list
Contact
News Center
og体育:News & Trends
Public information
Learn latest news of our company
follow developments of our company
News & Trends
14
2023-12
Salubris' innovative drugs Allisartan and Ena...
10
2023-10
New overseas clinical progress of JK07 for the tre...
08
2023-10
SAL0120 tablets for treatment of IgA nephropathy a...
10
2023-08
Vena cava filter system (SaExten®) approved by NMP...
09
2023-06
Enarodustat(恩那罗®) Approved by NMPA for Treatmen...
Learn more News & Trends
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7fDzSfyJvbjbD",ck:"K9y7fDzSfyJvbjbD"});
谈球吧体育(中国) - 官网app下载
OG体育(中国) - 官方网站
OG体育·(中国)平台
og体育(中国)- app下载